Akers v. AstraZeneca Pharmaceuticals LP

CourtDistrict Court, W.D. Oklahoma
DecidedSeptember 9, 2024
Docket5:23-cv-01067
StatusUnknown

This text of Akers v. AstraZeneca Pharmaceuticals LP (Akers v. AstraZeneca Pharmaceuticals LP) is published on Counsel Stack Legal Research, covering District Court, W.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Akers v. AstraZeneca Pharmaceuticals LP, (W.D. Okla. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF OKLAHOMA

JAMIE AKERS, ) ) Plaintiff, ) ) v. ) Case No. CIV-23-01067-JD ) ASTRAZENECA PHARMACEUTICALS, ) LP, ) ) Defendant. )

ORDER Before the Court is Defendant AstraZeneca Pharmaceuticals, LP’s (“AstraZeneca”) Motion to Dismiss (“Motion”) [Doc. No. 16], which seeks dismissal of Plaintiff Jamie Akers’s (“Akers”) complaint [Doc. No. 1] for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). Akers responded in opposition [Doc. No. 22], and AstraZeneca replied [Doc. No. 23]. For the reasons stated below, the Court denies AstraZeneca’s Motion. I. BACKGROUND1 Akers worked for AstraZeneca for approximately 15 years, most recently in sales. Compl. [Doc. No. 1] ¶¶ 13–14. In August 2021, AstraZeneca required its employees to begin testing weekly for COVID-19. Id. ¶ 15. Then, in January 2022, AstraZeneca announced that all employees would need to verify that they received a COVID-19

1 As explained below, the Court recounts the facts based on the well-pleaded allegations and construes them in the light most favorable to Akers, and the Court considers the religious accommodation request form. vaccination to remain employed there. Id. ¶ 17. The next month, AstraZeneca notified employees that if they qualified for a medical or religious exemption to the vaccination

policy, they could continue weekly testing for COVID-19 rather than receive the vaccine. Id. ¶¶ 20–21. Akers applied for a religious exemption to the vaccination policy. Id. ¶ 24. In her application, Akers stated that, as a Catholic, she objected to using medications generated using aborted fetal cells and her belief that the vaccine would defile the sanctity of her body. Id. ¶¶ 25–26. She also noted her distrust of the “experimental injection” and her

belief that the “natural immunity” she developed after previously contracting the virus would prevent COVID-19 more effectively than the vaccine. [Doc. No. 16-2 at 1]. Akers attached a letter from a Catholic pastor, who explained that Akers has “a moral duty to refuse the use of medical products, including certain vaccines that are created using human cell lines derived from abortion,” and that she “is morally required to obey . . . her

conscience.” Compl. [Doc. No. 1] ¶ 25. “Therefore,” the letter concluded, “if a Catholic comes to an informed judgment that he or she should not receive a vaccine, then the Catholic Church requires that the person follow this judgment of conscience and refuse the vaccine.” Id. AstraZeneca rejected Akers’s request for a religious accommodation, citing in part

the “undue hardship” that would result from “business disruption/increased costs resulting from illness-related absences.” Id. ¶¶ 28, 32. However, AstraZeneca approved a “substantially similar accommodation request” from a younger employee who did not belong to Akers’s church. Id. ¶¶ 35, 37. Having rejected Akers’s request for an accommodation, AstraZeneca terminated Akers without severance on April 29, 2022, because of her refusal to receive the COVID-19 vaccination. Id. ¶¶ 38–39.

Akers then filed a Charge of Discrimination with the United States Equal Employment Opportunity Commission (“EEOC”) on September 6, 2022. Id. ¶ 10. After the EEOC dismissed her Charge of Discrimination, Akers filed this suit, asserting claims of religious discrimination under Title VII of the federal Civil Rights Act of 1964 and the Oklahoma Anti-Discrimination Act. Id. ¶¶ 11, 45.

II. LEGAL STANDARD “To survive a motion to dismiss” under Rule 12(b)(6), “a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is

liable for the misconduct alleged.” Id. Under this standard, the Court must “accept the well-pleaded facts alleged as true and view them in the light most favorable to the plaintiff.” Clinton v. Sec. Benefit Life Ins. Co., 63 F.4th 1264, 1275 (10th Cir. 2023). However, “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice,” and the Court must “draw on its judicial

experience and common sense” to determine whether a complaint states a plausible claim for relief. Iqbal, 556 U.S. at 678–79. “In other words, dismissal under Rule 12(b)(6) is appropriate if the complaint alone is legally insufficient to state a claim.” Brokers’ Choice of Am., Inc. v. NBC Universal, Inc., 861 F.3d 1081, 1104–05 (10th Cir. 2017). “Generally, a court considers only the contents of the complaint when ruling on a 12(b)(6) motion.” Clinton, 63 F.4th at 1275 (quoting Berneike v. CitiMortgage, Inc., 708

F.3d 1141, 1146 (10th Cir. 2013)). However, “[e]xceptions to this general rule include the following: documents incorporated by reference in the complaint; documents referred to in and central to the complaint, when no party disputes its authenticity; and matters of which a court may take judicial notice.” Id. (alteration in original) (quoting Berneike, 708 F.3d at 1146). Although Akers’s complaint does not expressly incorporate it by reference, the Court considers Akers’s religious accommodation request form because she

repeatedly refers to the application in her complaint, Compl. [Doc. No. 1] ¶¶ 24–28, the request is central to her complaint, and Akers does not dispute the authenticity of the document attached to the Motion as Exhibit 2. See N. Arapaho Tribe v. Becerra, 61 F.4th 810, 814 (10th Cir.), cert. granted, 144 S. Ct. 419 (2023), aff’d sub nom. Becerra v. San Carlos Apache Tribe, 144 S. Ct. 1428 (2024) (considering documents referenced in the

complaint on a Rule 12(b)(6) motion where the documents are central to the complaint and the parties do not dispute their authenticity). III. ANALYSIS AstraZeneca seeks dismissal of Akers’s claim, arguing that she has failed to state a claim under either Title VII or the Oklahoma Anti-Discrimination Act (“OADA”).

A. Akers has sufficiently pleaded a claim under Title VII. Title VII of the Civil Rights Act of 1964 makes it unlawful for an employer “to discharge any individual, or otherwise to discriminate against any individual with respect to his compensation, terms, conditions, or privileges of employment, because of such individual’s . . . religion.” 42 U.S.C. § 2000e-2(a)(1). This proscription is “often referred to as the ‘disparate treatment’ (or ‘intentional discrimination’) provision” of Title VII.

E.E.O.C. v. Abercrombie & Fitch Stores, Inc., 575 U.S. 768, 771 (2015). The statute defines “religion” as including “all aspects of religious observance and practice, as well as belief, unless an employer demonstrates that he is unable to reasonably accommodate to an employee’s or prospective employee’s religious observance or practice without undue hardship on the conduct of the employer’s business.” 42 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Khalik v. United Air Lines
671 F.3d 1188 (Tenth Circuit, 2012)
Berneike v. CitiMortgage, Inc.
708 F.3d 1141 (Tenth Circuit, 2013)
Jones v. Needham
856 F.3d 1284 (Tenth Circuit, 2017)
Tabura v. Kellogg USA
880 F.3d 544 (Tenth Circuit, 2018)
Bennett v. Windstream Communications, Inc.
792 F.3d 1261 (Tenth Circuit, 2015)
Northern Arapaho Tribe v. Becerra
61 F.4th 810 (Tenth Circuit, 2023)
Clinton v. Security Benefit Life
63 F.4th 1264 (Tenth Circuit, 2023)
Kenneth Ringhofer v. Mayo Clinic Ambulance
102 F.4th 894 (Eighth Circuit, 2024)
Najean Lucky v. Landmark Med. of Mich., P.C.
103 F.4th 1241 (Sixth Circuit, 2024)
Megan Passarella v. Aspirus, Inc.
108 F.4th 1005 (Seventh Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Akers v. AstraZeneca Pharmaceuticals LP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/akers-v-astrazeneca-pharmaceuticals-lp-okwd-2024.